Autres langues PuraPharm Corporation Limited

Actions

1498

KYG7306Y1044

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:08:17 07/05/2024			Varia. 5j.	Varia. 1 janv.
0,76 ^HKD	+1,33%		+4,11%	-15,56%

01/04	La perte nette de PuraPharm diminue en 2023 ; les revenus chutent de 9%.	MT
28/03	PuraPharm Corporation Limited annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

PuraPharm's Net Loss Shrinks in 2023; Revenue Falls 9%	01/04
PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
PuraPharm Corporation Limited Announces Cessation of Norimoto Hisayoshi as Executive Director	20/11
PuraPharm Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
PuraPharm Corporation Limited Announces Appointment of Leung Stephen Kwok Keung as Non-Executive Director	14/06/23
PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022	21/03/23
PuraPharm Grants Nearly 8 Million Options	30/12/22
Purapharm Swings to H1 Loss on Lower Sales	29/08/22
PuraPharm Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022	28/08/22
Purapharm Corporation Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2022	12/08/22
Purapharm Corporation Limited Announces Retirement of Non-Executive Director	31/03/22
Purapharm Turns to Loss in 2021 on Impairment Loss of Goodwill; Shares Fall 4%	30/03/22
PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2021	29/03/22
Purapharm Forecasts Turn to Loss in 2021	28/02/22
PuraPharm Corporation Limited Provides Earnings Guidance for the Year Ending December 31, 2021	25/02/22
Purapharm Corporation Limited Announces Change of Headquarter And principal Place of Business in Hong Kong	16/12/21
Purapharm : Cancels Sale of Intellectual Property Assets to BAGI Research	06/10/21
PuraPharm : Books Higher Profit, Revenue in H1	23/08/21
Purapharm Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2021	20/08/21
PuraPharm : RESIGNATION OF CHIEF FINANCIAL OFFICER, CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE	29/07/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues PuraPharm Corporation Limited

Actions

1498

KYG7306Y1044

Autres langues

Filtres